Emphasize Nondrug Measures for Overactive Bladder...Not Meds

March 2021

Gemtesa (vibegron) will be a new Rx med for overactive bladder.

It’s similar to Myrbetriq (mirabegron). Both stimulate beta-3 receptors, causing the bladder to relax...and are dosed once daily.

Think of them as alternatives to antimuscarinics (oxybutynin, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Share Facts About the New Viral Vector COVID-19 Vaccine
Immunizations Reduce Risk of Injury and Manage Pain From IM Vaccinations
Asthma Weigh Pros and Cons of SMART for Moderate to Severe Asthma
Headache Start Treatment ASAP for Cluster Headaches
Opioids Stay Vigilant When Prescribing Fentanyl
IBS Sort Out Meds for Irritable Bowel Syndrome
Prediabetes Focus on Lifestyle Changes to Help Tackle Prediabetes
Overactive Bladder Emphasize Nondrug Measures for Overactive Bladder...Not Meds
HIV & AIDS Watch for Cabenuva, a New Monthly Injectable for HIV
COVID-19 Guide Use of Tocilizumab for COVID-19 Based on New Data
Surgery Focus on Safe Use of Local Anesthetics for Post-Op Pain
Pediatrics Assess Best Options for Neonatal Opioid Withdrawal Protocols